查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953556

生物程序用袋及容器市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、產品類型、最終用戶、地區和競爭格局分類，2021-2031年

Bioprocess Bags & Containers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Product Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物程序袋和容器市場預計將從 2025 年的 37.6 億美元大幅成長至 2031 年的 81.1 億美元，複合年成長率為 13.67%。

這些一次性或半耐用容器專為生物製藥工作流程中無菌液體的安全處理和運輸而設計，與傳統的不銹鋼容器相比，其顯著優勢在於無需清洗驗證，並可縮短生產前置作業時間。推動這一成長的主要因素是全球對生物製藥和疫苗日益成長的需求，這需要靈活且擴充性的生產能力。正如歐洲製藥工業協會聯合會 (EFPIA) 在 2024 年指出的那樣，歐洲以研發為導向的製藥業在研發方面的投資約為 550 億歐元，這清楚地表明，大量資本投資正支持依賴這些流體管理解決方案的開發平臺。

市場概覽
預測期 2027-2031
市場規模：2025年 37.6億美元
市場規模：2031年 81.1億美元
複合年成長率：2026-2031年 13.67%
成長最快的細分市場 上游工程
最大的市場 北美洲

儘管前景樂觀，但一次性耗材產生的塑膠廢棄物在環境永續性方面仍面臨許多挑戰。隨著產量增加以滿足全球醫療保健需求，該行業面臨著如何管理這些容器中使用的複雜多層聚合物薄膜的處置和回收這一艱鉅任務。如果沒有有效的循環經濟策略，該行業可能會面臨嚴格的監管和不斷上漲的處置成本，最終阻礙一次性生物製程系統的長期應用。

市場促進因素

隨著製造商將成本效益和營運柔軟性置於優先地位，向一次性生物製程技術的快速轉型正在從根本上重塑市場格局。以一次性袋和容器取代傳統的不鏽鋼基礎設施，無需複雜的就地清洗(CIP) 和原位蒸氣滅菌 (SIP) 系統，從而降低了資本投資。這種轉變縮短了設施的運作週期，並最大限度地降低了交叉污染的風險，這對於尋求運作的多產品生產設施至關重要。這種對彈性技術的投入也體現在重大資本計劃中。例如，富士膠片迪奧辛斯生物技術公司 (Fujifilm Diosynth Biotechnologies) 於 2024 年 4 月宣布追加 12 億美元投資，用於擴展其大規模細胞培養網路，從而直接增強其依賴一次性容器的靈活生產方法。

此外，全球對生物製藥和生物相似藥日益成長的需求，正成為推動流體管理耗材需求成長的重要外部因素。隨著業界從小分子藥物轉向大分子療法，從上游工程到下游製程中安全、擴充性且無菌的流體處理變得愈發重要。監理核准也印證了這個趨勢。美國食品藥物管理局（FDA）於2024年1月發布的《2023年新藥核准報告》列出了17項新的生物製藥核准申請，凸顯了需要特殊防護技術的複雜療法的核准進程。為了滿足這項需求，三星生物製劑等合作夥伴公司正在擴大營運規模，預計2024年年營收將達到3.69兆韓元。這一數字與生物製程容器使用量的成長相吻合。

市場挑戰

一次性耗材產生的塑膠廢棄物的環境永續性是限制全球生物程序袋和容器市場成長的主要障礙。隨著生物製藥生產的擴張，不可回收的多層聚合物廢棄物的累積給製造商帶來了巨大的財務和合規責任。這項挑戰直接限制了市場擴張，因為旨在實現永續性目標的公司可能會減少一次性系統的使用，以降低因環境影響增加而帶來的聲譽風險和監管處罰。因此，與廢棄物管理相關的複雜物流成本增加，推高了總擁有成本 (TCO)，這可能會抵消通常推動這些技術應用的效率提升。

生物製程系統聯盟 (Bio-Process Systems Alliance) 2024 年發布的產業數據顯示，預計到 2028 年，生物製藥生產相關的塑膠廢棄物將達到每年約 11,700 公噸。日益成長的廢棄物數量給現有的廢棄物管理基礎設施帶來了沉重負擔。隨著日益嚴格的環境法規即將訂定，目前生物污染薄膜回收效率低下，迫使製造商必須採用成本高昂的焚化或專門的掩埋處理方式。這種經濟負擔限制了市場發展，阻礙了在注重成本的生產環境中，傳統不銹鋼設備轉向一次性替代品的轉變。

市場趨勢

一個顯著的趨勢是細胞和基因治療 (CGT) 工作流程中擴大使用生物袋。這與傳統生物製藥以大規模生產為中心的模式形成鮮明對比。與在大型生物反應器中生產的單株抗體不同，自體和異體移植療法需要小型、封閉的2D和3D生物製程容器來處理患者特異性批次，並確保低溫儲存和運輸過程中的安全。這項要求促使製造商創新專用薄膜技術，以在超低溫環境下保持高價值、小批量產品的無菌性和完整性。再生醫學聯盟 (Alliance for Regenerative Medicine) 於 2025 年 1 月發布的《產業趨勢簡報》重點強調了這一領域的成長，該簡報指出，該領域的投資成長了 30%，表明依賴這些先進的隔離解決方案的強勁產品線擴張勢頭。

同時，一次性解決方案正顯著擴展至下游工藝，其應用範圍已從基本的緩衝液儲存擴展到複雜的純化、填充和表面處理工程。傳統上，一次性袋用於上游工程正在推動層析法、病毒去活化和最終製劑製程中一次性組件的應用。這種轉變最大限度地減少了操作空間，並消除了與不銹鋼管道相關的清潔驗證瓶頸。領先的製藥公司正在檢驗向整合式一次性生產線的轉型；例如，諾華公司於2025年4月宣布，將在五年內投資230億美元，用於構建端到端生產能力，其中包括siRNA技術，該技術在下游製程中高度依賴一次性流體通道。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生物程序用袋與容器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依應用領域（上游工程、下游製程、製程開發、其他）
    • 產品類型（2D生物製程袋/容器、3D生物製程袋/容器）
    • 按最終用戶（製藥和生物製藥公司、學術和研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生物製程用袋與容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物程序用袋和容器的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生物製程用袋和容器的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物程序用袋和容器的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物程序用袋與容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球生物程序用袋與容器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Meissner Filtration Products, Inc.
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Danaher Corporation
  • Merck KGaA
  • Saint-Gobain
  • Corning Incorporated
  • Entegris
  • PROAnalytics, LLC
  • CellBios Healthcare and Lifesciences Pvt Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23876

The Global Bioprocess Bags & Containers Market is projected to expand significantly, rising from USD 3.76 Billion in 2025 to USD 8.11 Billion by 2031, representing a compound annual growth rate of 13.67%. These disposable or semi-durable vessels are designed for the safe handling and transport of sterile fluids within biopharmaceutical workflows, offering a distinct advantage over traditional stainless steel options by eliminating cleaning validation needs and shortening production turnaround times. A key factor driving this growth is the intense global demand for biologics and vaccines, which requires adaptable and scalable manufacturing capabilities. As noted by the European Federation of Pharmaceutical Industries and Associations in 2024, the research-based pharmaceutical sector invested approximately 55,000 million euros in R&D across Europe, highlighting the massive capital supporting development pipelines that depend on these fluid management solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.76 Billion
Market Size 2031USD 8.11 Billion
CAGR 2026-203113.67%
Fastest Growing SegmentUpstream Process
Largest MarketNorth America

Despite this positive outlook, the market encounters a substantial obstacle regarding the environmental sustainability of plastic waste produced by disposable consumables. As production volumes increase to address global health demands, the industry faces the difficult task of managing the disposal and recycling of the complex multi-layer polymer films utilized in these containers. If effective circular economy strategies are not adopted, the sector may face stringent regulatory measures and rising disposal costs, which could ultimately hinder the widespread long-term adoption of disposable bioprocessing systems.

Market Driver

The rapid shift toward single-use bioprocessing technologies is fundamentally reshaping the market as manufacturers prioritize cost efficiency and operational flexibility. By replacing traditional stainless steel infrastructure, single-use bags and containers reduce capital expenditures by eliminating the need for elaborate clean-in-place and steam-in-place systems. This transition enables faster facility turnover and minimizes cross-contamination risks, a crucial benefit for multiproduct facilities seeking to maximize operational uptime. This commitment to flexible technology is reflected in major capital projects, such as Fujifilm Diosynth Biotechnologies' April 2024 announcement of an additional 1.2 billion USD investment to expand its large-scale cell culture network, directly bolstering flexible production methods reliant on disposable containment.

Additionally, the escalating global demand for biologics and biosimilars acts as a pivotal external force driving the volume of fluid management consumables. As the industry moves from small-molecule drugs to large-molecule therapies, the necessity for secure, scalable, and sterile liquid handling throughout upstream and downstream processes has intensified. Regulatory approvals underscore this trend; the U.S. Food and Drug Administration's 'New Drug Therapy Approvals 2023' report, released in January 2024, noted the approval of 17 new biologics license applications, emphasizing the commercialization of complex therapeutics requiring specialized containment. To accommodate this demand, partners like Samsung Biologics are scaling operations, reporting 3.69 trillion KRW in annual revenue in 2024, a figure that correlates with the heightened usage of bioprocess containers.

Market Challenge

The environmental sustainability of plastic waste from disposable consumables represents a major barrier to the growth of the Global Bioprocess Bags & Containers Market. As biopharmaceutical production scales, the accumulation of non-recyclable, multi-layer polymer waste generates significant financial and compliance liabilities for manufacturers. This challenge directly restricts market expansion because companies aiming to meet corporate sustainability goals may curtail their use of single-use systems to mitigate reputational risks and regulatory penalties linked to an increased environmental footprint. Consequently, the complicated logistics involved in managing end-of-life disposables increase the total cost of ownership, potentially negating the efficiency gains that usually encourage the adoption of these technologies.

Industry data provided by the Bio-Process Systems Alliance in 2024 indicates that plastic waste related to biopharmaceutical manufacturing is expected to reach nearly 11,700 metric tons annually by 2028. This growing volume exerts tremendous strain on existing waste management infrastructures. With strict environmental mandates approaching, the current inability to effectively recycle these bio-contaminated films compels manufacturers to rely on expensive incineration or specialized landfilling options. This financial strain acts as a restraint on the market, deterring the transition from traditional stainless steel equipment to disposable alternatives in cost-sensitive manufacturing environments.

Market Trends

A significant trend is the increasing use of bags in cell and gene therapy (CGT) workflows, which diverges from the volume-centric demands of traditional biologics. In contrast to monoclonal antibodies produced in large-scale bioreactors, autologous and allogeneic therapies require smaller, closed-system 2D and 3D bioprocess containers to handle patient-specific batches and ensure safety during cryogenic storage and transport. This requirement compels manufacturers to innovate specialized film technologies that retain integrity at ultra-low temperatures while preserving sterility for high-value, low-volume products. The growth in this area is highlighted by the Alliance for Regenerative Medicine's January 2025 'State of the Industry Briefing', which reported a 30 percent increase in sector investment, indicating strong pipeline expansion dependent on these advanced containment solutions.

Simultaneously, the market is witnessing a significant expansion of single-use solutions into downstream processing, extending beyond basic buffer storage to include complex purification and fill-finish tasks. While disposable bags were traditionally used for upstream media preparation, the push for end-to-end continuous manufacturing is fostering the adoption of single-use assemblies for chromatography, viral inactivation, and final formulation. This shift minimizes the operational footprint and removes cleaning validation bottlenecks associated with stainless steel piping. Major pharmaceutical companies are validating this move toward integrated disposable lines; for instance, Novartis announced in April 2025 a 23 billion USD investment over five years to build end-to-end manufacturing capabilities, including siRNA technologies that rely heavily on downstream single-use fluid pathways.

Key Market Players

  • Meissner Filtration Products, Inc.
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Danaher Corporation
  • Merck KGaA
  • Saint-Gobain
  • Corning Incorporated
  • Entegris
  • PROAnalytics, LLC
  • CellBios Healthcare and Lifesciences Pvt Ltd.

Report Scope

In this report, the Global Bioprocess Bags & Containers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioprocess Bags & Containers Market, By Application

  • Upstream Processes
  • Downstream Processes
  • Process Development
  • Others

Bioprocess Bags & Containers Market, By Product Type

  • 2D Bioprocess Bags and Containers
  • 3D Bioprocess Bags
  • Containers

Bioprocess Bags & Containers Market, By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes
  • Others

Bioprocess Bags & Containers Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Bags & Containers Market.

Available Customizations:

Global Bioprocess Bags & Containers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Bags & Containers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Upstream Processes, Downstream Processes, Process Development, Others)
    • 5.2.2. By Product Type (2D Bioprocess Bags and Containers, 3D Bioprocess Bags, Containers)
    • 5.2.3. By End User (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Bioprocess Bags & Containers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Product Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bioprocess Bags & Containers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bioprocess Bags & Containers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bioprocess Bags & Containers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By End User

7. Europe Bioprocess Bags & Containers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Product Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bioprocess Bags & Containers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Bioprocess Bags & Containers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bioprocess Bags & Containers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bioprocess Bags & Containers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bioprocess Bags & Containers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Bioprocess Bags & Containers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Product Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bioprocess Bags & Containers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bioprocess Bags & Containers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bioprocess Bags & Containers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bioprocess Bags & Containers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bioprocess Bags & Containers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Bioprocess Bags & Containers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Product Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bioprocess Bags & Containers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Bioprocess Bags & Containers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Bioprocess Bags & Containers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By End User

10. South America Bioprocess Bags & Containers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Product Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bioprocess Bags & Containers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Bioprocess Bags & Containers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Bioprocess Bags & Containers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bioprocess Bags & Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Meissner Filtration Products, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Sartorius AG
  • 15.4. Danaher Corporation
  • 15.5. Merck KGaA
  • 15.6. Saint-Gobain
  • 15.7. Corning Incorporated
  • 15.8. Entegris
  • 15.9. PROAnalytics, LLC
  • 15.10. CellBios Healthcare and Lifesciences Pvt Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer